MII Implementierungsleitfaden Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: mii-exa-befund-bundle-befund-fgfr2-fusion

Raw xml | Download


<Bundle xmlns="http://hl7.org/fhir">
  <id value="mii-exa-befund-bundle-befund-fgfr2-fusion"/>
  <language value="de"/>
  <type value="transaction"/>
  <timestamp value="2022-12-16T13:47:00+01:00"/>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-patient-fgfr2-fusion"/>
    <resource>
      <Patient>
        <id value="mii-exa-molgen-patient-fgfr2-fusion"/>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <identifier>
          <use value="usual"/>
          <type>
            <coding>
              <system
                      value="http://terminology.hl7.org/CodeSystem/v3-ObservationValue"/>
              <code value="PSEUDED"/>
            </coding>
          </type>
          <system value="https://www.charite.de/fhir/sid/pseudonym"/>
          <value value="3337167192"/>
        </identifier>
        <gender value="female"/>
        <birthDate value="1964-05"/>
        <deceasedBoolean value="false"/>
        <address>
          <type value="both"/>
          <postalCode value="10"/>
          <country value="DE"/>
        </address>
      </Patient>
    </resource>
    <request>
      <method value="PUT"/>
      <url value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-lab"/>
    <resource>
      <Practitioner>
        <id value="mii-exa-molgen-practitioner-lab"/>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <active value="true"/>
        <name>
          <use value="official"/>
          <text value="Dr. Daniel Schmidt"/>
          <family value="Schmidt"/>
          <given value="Daniel"/>
          <prefix value="Dr."/>
        </name>
      </Practitioner>
    </resource>
    <request>
      <method value="PUT"/>
      <url value="Practitioner/mii-exa-molgen-practitioner-lab"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-physician"/>
    <resource>
      <Practitioner>
        <id value="mii-exa-molgen-practitioner-physician"/>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <active value="true"/>
        <name>
          <use value="official"/>
          <text value="Dr. Linda Rubens"/>
          <family value="Rubens"/>
          <given value="Linda"/>
          <prefix value="Dr."/>
        </name>
      </Practitioner>
    </resource>
    <request>
      <method value="PUT"/>
      <url value="Practitioner/mii-exa-molgen-practitioner-physician"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-befundbericht-fgfr2-fusion"/>
    <resource>
      <DiagnosticReport>
        <id value="mii-exa-molgen-befundbericht-fgfr2-fusion"/>
        <meta>
          <profile
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/molekulargenetischer-befundbericht|2027.0.0-ballot.1"/>
          <profile
                   value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report|3.0.0"/>
        </meta>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <extension
                   url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action">
          <valueReference>🔗 
            <reference
                       value="Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
          </valueReference>
        </extension>
        <basedOn>🔗 
          <reference
                     value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
        </basedOn>
        <status value="final"/>
        <category>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
            <code value="GE"/>
            <display value="Genetics"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="51969-4"/>
            <display value="Genetic analysis report"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
        </subject>
        <performer>🔗 
          <reference value="Practitioner/mii-exa-molgen-practitioner-lab"/>
        </performer>
        <result>🔗 
          <reference
                     value="Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
        </result>
        <result>🔗 
          <reference
                     value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
        </result>
        <result>🔗 
          <reference
                     value="Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
        </result>
        <conclusion
                    value="Nachweis FGFR2-Fusion. Empfehlung: Hochselektive FGFR-Inhibitor-Therapie."/>
      </DiagnosticReport>
    </resource>
    <request>
      <method value="PUT"/>
      <url
           value="DiagnosticReport/mii-exa-molgen-befundbericht-fgfr2-fusion"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-anforderung-fgfr2-fusion"/>
    <resource>
      <ServiceRequest>
        <id value="mii-exa-molgen-anforderung-fgfr2-fusion"/>
        <meta>
          <profile
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test|2027.0.0-ballot.1"/>
        </meta>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <identifier>
          <system value="https://www.charite.de/fhir/auftragsnummern"/>
          <value value="PRK4QE59A"/>
        </identifier>
        <status value="active"/>
        <intent value="order"/>
        <category>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="108252007"/>
            <display value="Laboratory procedure (procedure)"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="405825005"/>
            <display value="Molecular genetic test (procedure)"/>
          </coding>
          <text
                value="Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom"/>
        </code>
        <subject>🔗 
          <reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
        </subject>
        <authoredOn value="2022-11-30"/>
        <requester>🔗 
          <reference
                     value="Practitioner/mii-exa-molgen-practitioner-physician"/>
        </requester>
        <reasonCode>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="109842005"/>
            <display value="Intrahepatic bile duct carcinoma (disorder)"/>
          </coding>
          <coding>
            <system value="http://fhir.de/CodeSystem/bfarm/icd-10-gm"/>
            <version value="2024"/>
            <code value="C22.1"/>
            <display value="Intrahepatisches Gallengangskarzinom"/>
          </coding>
        </reasonCode>
      </ServiceRequest>
    </resource>
    <request>
      <method value="PUT"/>
      <url value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-variante-fgfr2-fusion"/>
    <resource>
      <Observation>
        <id value="mii-exa-molgen-variante-fgfr2-fusion"/>
        <meta>
          <profile
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/variante|2027.0.0-ballot.1"/>
          <profile
                   value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/variant|3.0.0"/>
        </meta>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <basedOn>🔗 
          <reference
                     value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
        </basedOn>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://terminology.hl7.org/CodeSystem/observation-category"/>
            <code value="laboratory"/>
            <display value="Laboratory"/>
          </coding>
        </category>
        <category>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
            <code value="GE"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="69548-6"/>
            <display value="Genetic variant assessment"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
        </subject>
        <effectiveDateTime value="2022-11-30"/>
        <valueCodeableConcept>
          <coding>
            <system value="http://loinc.org"/>
            <code value="LA9633-4"/>
            <display value="Present"/>
          </coding>
        </valueCodeableConcept>
        <method>
          <coding>
            <system value="http://loinc.org"/>
            <code value="LA26398-0"/>
            <display value="Sequencing"/>
          </coding>
          <coding>
            <system value="http://loinc.org"/>
            <code value="86206-0"/>
            <display
                     value="Whole genome sequence analysis in Blood or Tissue by Molecular genetics method"/>
          </coding>
        </method>
        <component>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="48018-6"/>
            </coding>
          </code>
          <valueCodeableConcept>
            <coding>
              <system value="http://www.genenames.org/geneId"/>
              <code value="HGNC:3689"/>
              <display value="FGFR2"/>
            </coding>
          </valueCodeableConcept>
        </component>
        <component>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="48019-4"/>
            </coding>
          </code>
          <valueCodeableConcept>
            <coding>
              <system value="http://sequenceontology.org"/>
              <code value="SO:0001565"/>
              <display value="gene_fusion"/>
            </coding>
          </valueCodeableConcept>
        </component>
        <component>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="95123-6"/>
            </coding>
          </code>
          <valueCodeableConcept>
            <coding>
              <system value="http://www.genenames.org/geneId"/>
              <code value="HGNC:3689::HGNC:2697"/>
              <display value="FGFR2::DBP"/>
            </coding>
          </valueCodeableConcept>
        </component>
      </Observation>
    </resource>
    <request>
      <method value="PUT"/>
      <url value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
    <resource>
      <Observation>
        <id value="mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
        <meta>
          <profile
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/diagnostische-implikation|2027.0.0-ballot.1"/>
          <profile
                   value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/diagnostic-implication|3.0.0"/>
        </meta>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://terminology.hl7.org/CodeSystem/observation-category"/>
            <code value="laboratory"/>
            <display value="Laboratory"/>
          </coding>
        </category>
        <category>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
            <code value="GE"/>
          </coding>
        </category>
        <code>
          <coding>
            <system
                    value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
            <code value="diagnostic-implication"/>
            <display value="Diagnostic Implication"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
        </subject>
        <effectiveDateTime value="2022-11-30"/>
        <performer>🔗 
          <reference value="Practitioner/mii-exa-molgen-practitioner-lab"/>
        </performer>
        <derivedFrom>🔗 
          <reference
                     value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
        </derivedFrom>
        <component>
          <code>
            <coding>
              <system
                      value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
              <code value="conclusion-string"/>
            </coding>
          </code>
          <valueString value="starke Überexpression (25-fach)"/>
        </component>
      </Observation>
    </resource>
    <request>
      <method value="PUT"/>
      <url
           value="Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
    <resource>
      <Observation>
        <id value="mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
        <meta>
          <profile
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/therapeutische-implikation|2027.0.0-ballot.1"/>
          <profile
                   value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication|3.0.0"/>
        </meta>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://terminology.hl7.org/CodeSystem/observation-category"/>
            <code value="laboratory"/>
            <display value="Laboratory"/>
          </coding>
        </category>
        <category>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
            <code value="GE"/>
          </coding>
        </category>
        <code>
          <coding>
            <system
                    value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
            <code value="therapeutic-implication"/>
            <display value="Therapeutic Implication"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
        </subject>
        <effectiveDateTime value="2022-11-30"/>
        <performer>🔗 
          <reference value="Practitioner/mii-exa-molgen-practitioner-lab"/>
        </performer>
        <derivedFrom>🔗 
          <reference
                     value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
        </derivedFrom>
        <component>
          <code>
            <coding>
              <system
                      value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
              <code value="conclusion-string"/>
            </coding>
          </code>
          <valueString
                       value="Hochselektiver FGFR2-Inhibitor RLY-4008 bei Patienten mit Cholangiokarzinomen und anderen soliden Tumoren, mit oder ohne FGFR- gerichtete Vortherapie."/>
        </component>
        <component>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="51963-7"/>
              <display value="Medication assessed [ID]"/>
            </coding>
          </code>
          <valueCodeableConcept>
            <coding>
              <system value="http://www.whocc.no/atc"/>
              <code value="L01EN"/>
              <display
                       value="Fibroblasten-Wachstumsfaktor-Rezeptor (FGFR)-Tyrosinkinase-Inhibitoren"/>
            </coding>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="1162485005"/>
              <display
                       value="Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)"/>
            </coding>
          </valueCodeableConcept>
        </component>
        <component>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="93044-6"/>
            </coding>
          </code>
          <valueCodeableConcept>
            <text value="m1c"/>
          </valueCodeableConcept>
        </component>
        <component>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="81259-4"/>
            </coding>
          </code>
          <valueCodeableConcept>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="109842005"/>
              <display value="Intrahepatic bile duct carcinoma (disorder)"/>
            </coding>
            <coding>
              <system value="http://fhir.de/CodeSystem/bfarm/icd-10-gm"/>
              <version value="2024"/>
              <code value="C22.1"/>
              <display value="Intrahepatisches Gallengangskarzinom"/>
            </coding>
          </valueCodeableConcept>
        </component>
      </Observation>
    </resource>
    <request>
      <method value="PUT"/>
      <url
           value="Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
    </request>
  </entry>
  <entry>
    <fullUrl
             value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
    <resource>
      <Task>
        <id value="mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
        <meta>
          <profile
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung|2027.0.0-ballot.1"/>
          <profile
                   value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation|3.0.0"/>
        </meta>
        <language value="de"/>
        <text>
          <status value="generated"/>
        </text>
        <basedOn>🔗 
          <reference
                     value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
        </basedOn>
        <status value="requested"/>
        <intent value="proposal"/>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="LA26421-0"/>
            <display value="Consider alternative medication"/>
          </coding>
          <text value="Hochselektive FGFR-Inhibitor-Therapie"/>
        </code>
        <for>🔗 
          <reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
        </for>
        <reasonReference>🔗 
          <reference
                     value="Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
        </reasonReference>
      </Task>
    </resource>
    <request>
      <method value="PUT"/>
      <url value="Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
    </request>
  </entry>
</Bundle>